Nora Therapeutics is an early stage specialty biopharmaceuticals company focusing on commercializing therapeutics to address issues in reproductive health. Based on medical research in immunology and supported by a strong intellectual property position, Nora’s lead therapeutic candidates are FDA-approved products repurposed to improve the likelihood for term pregnancy in women who suffer from repeated assisted reproductive failure (i.e., in vitro fertilization or IVF) and recurrent miscarriage. Website: www.noratherapeutics.com